Cargando…
The Antitumor Effect of TPD52L2 Silencing on Oxaliplatin-Resistant Gastric Carcinoma Is Related to Endoplasmic Reticulum Stress In Vitro
Tumor protein D52-like 2 or simply TPD52L2 belongs to the TPD52 family which has been implicated in a variety of human carcinomas. However, the TPD52L2 function in the gastric carcinoma oxaliplatin (OXA) resistance remains elusive. The main objective of this study is to evaluate the TPD52L2 effect i...
Autores principales: | Zhang, Yu, Yang, Dejun, Wei, Ziran, Zhang, Xin, Hu, Zunqi, Fu, Hongbing, Xu, Jiapeng, Wang, Weijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789433/ https://www.ncbi.nlm.nih.gov/pubmed/35087592 http://dx.doi.org/10.1155/2022/4451178 |
Ejemplares similares
-
Comparison of Docetaxel + Oxaliplatin + S-1 vs Oxalipatin + S-1 as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Propensity Score Matched Analysis
por: Zhang, Xin, et al.
Publicado: (2020) -
Five-long non-coding RNA risk score system for the effective prediction of gastric cancer patient survival
por: Hu, Zunqi, et al.
Publicado: (2019) -
TRIM32 promotes cell proliferation and invasion by activating β‐catenin signalling in gastric cancer
por: Wang, Changming, et al.
Publicado: (2018) -
A four-lncRNA signature for predicting prognosis of recurrence patients with gastric cancer
por: Chen, Qiang, et al.
Publicado: (2021) -
Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma
por: Wang, Ying, et al.
Publicado: (2015)